Cargando…

Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions

Background: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterized by motor and vocal tics. The underlying etiology remains largely unknown, and GTS is considered as a complex multifactorial disorder associated with effects of several genes in combination with environme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjerregaard, Victoria A., Schönewolf-Greulich, Bitten, Juel Rasmussen, Lene, Desler, Claus, Tümer, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105681/
https://www.ncbi.nlm.nih.gov/pubmed/32265818
http://dx.doi.org/10.3389/fneur.2020.00163
_version_ 1783512448769196032
author Bjerregaard, Victoria A.
Schönewolf-Greulich, Bitten
Juel Rasmussen, Lene
Desler, Claus
Tümer, Zeynep
author_facet Bjerregaard, Victoria A.
Schönewolf-Greulich, Bitten
Juel Rasmussen, Lene
Desler, Claus
Tümer, Zeynep
author_sort Bjerregaard, Victoria A.
collection PubMed
description Background: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterized by motor and vocal tics. The underlying etiology remains largely unknown, and GTS is considered as a complex multifactorial disorder associated with effects of several genes in combination with environmental factors. The inner mitochondrial membrane peptidase, subunit 2 (IMMP2L) has been suggested as one of the susceptibility genes for GTS, and IMMP2L-deficient mouse and human cells show increased levels of mitochondrial oxidative stress and altered cell fate programming. Hence, a potential involvement of IMMP2L-induced mitochondrial dysfunction in GTS pathology is yet to be elucidated. To address this, we investigated mitochondrial function in a group of GTS patients with intragenic IMMP2L deletions and compared with GTS without IMMP2L deletions and healthy controls. Methods: Mitochondrial function in fibroblasts from GTS patients and non-GTS parents (with and without IMMP2L deletions) compared to healthy controls were evaluated by measuring mitochondrial superoxide production, mitochondrial membrane potential, mitochondrial mass, and mitochondrial respiration. In addition, we evaluated apoptosis and senescence. Results: None of the mitochondrial parameters assessed in this study were significantly distinctive when comparing GTS patients with and without IMMP2L deletions against healthy controls or parents with or without IMMP2L deletions, and we did not observe altered cell programming. Conclusion: This study suggests that IMMP2L deletions do not lead to a substantial general mitochondrial dysfunction in GTS fibroblasts. Assessing a large cohort of controls and patients of similar age and gender would possibly reveal small differences in mitochondrial function. However, it is possible that IMMP2L variants affect mitochondrial function during specific instances of stress stimuli or in brain regions suggested to be affected in GTS.
format Online
Article
Text
id pubmed-7105681
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71056812020-04-07 Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions Bjerregaard, Victoria A. Schönewolf-Greulich, Bitten Juel Rasmussen, Lene Desler, Claus Tümer, Zeynep Front Neurol Neurology Background: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterized by motor and vocal tics. The underlying etiology remains largely unknown, and GTS is considered as a complex multifactorial disorder associated with effects of several genes in combination with environmental factors. The inner mitochondrial membrane peptidase, subunit 2 (IMMP2L) has been suggested as one of the susceptibility genes for GTS, and IMMP2L-deficient mouse and human cells show increased levels of mitochondrial oxidative stress and altered cell fate programming. Hence, a potential involvement of IMMP2L-induced mitochondrial dysfunction in GTS pathology is yet to be elucidated. To address this, we investigated mitochondrial function in a group of GTS patients with intragenic IMMP2L deletions and compared with GTS without IMMP2L deletions and healthy controls. Methods: Mitochondrial function in fibroblasts from GTS patients and non-GTS parents (with and without IMMP2L deletions) compared to healthy controls were evaluated by measuring mitochondrial superoxide production, mitochondrial membrane potential, mitochondrial mass, and mitochondrial respiration. In addition, we evaluated apoptosis and senescence. Results: None of the mitochondrial parameters assessed in this study were significantly distinctive when comparing GTS patients with and without IMMP2L deletions against healthy controls or parents with or without IMMP2L deletions, and we did not observe altered cell programming. Conclusion: This study suggests that IMMP2L deletions do not lead to a substantial general mitochondrial dysfunction in GTS fibroblasts. Assessing a large cohort of controls and patients of similar age and gender would possibly reveal small differences in mitochondrial function. However, it is possible that IMMP2L variants affect mitochondrial function during specific instances of stress stimuli or in brain regions suggested to be affected in GTS. Frontiers Media S.A. 2020-03-24 /pmc/articles/PMC7105681/ /pubmed/32265818 http://dx.doi.org/10.3389/fneur.2020.00163 Text en Copyright © 2020 Bjerregaard, Schönewolf-Greulich, Juel Rasmussen, Desler and Tümer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Bjerregaard, Victoria A.
Schönewolf-Greulich, Bitten
Juel Rasmussen, Lene
Desler, Claus
Tümer, Zeynep
Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
title Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
title_full Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
title_fullStr Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
title_full_unstemmed Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
title_short Mitochondrial Function in Gilles de la Tourette Syndrome Patients With and Without Intragenic IMMP2L Deletions
title_sort mitochondrial function in gilles de la tourette syndrome patients with and without intragenic immp2l deletions
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105681/
https://www.ncbi.nlm.nih.gov/pubmed/32265818
http://dx.doi.org/10.3389/fneur.2020.00163
work_keys_str_mv AT bjerregaardvictoriaa mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions
AT schonewolfgreulichbitten mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions
AT juelrasmussenlene mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions
AT deslerclaus mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions
AT tumerzeynep mitochondrialfunctioningillesdelatourettesyndromepatientswithandwithoutintragenicimmp2ldeletions